We consider your selection and will only use the data you have approved us to gather.
These cookies help making a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
These cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously. With this information we can constantly improve the experience we offer on our website.
These cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
Augmentation of width of keratinised tissue around prosthetic restoration
Aim: Augmentation of the width of keratinised tissue around prosthetic restoration, avoiding the patient morbidity caused by autogenous soft-tissue grafts.
Conclusion: Mucograft® (prototype)* is as effective and predictable as connective tissue graft (CTG) to gain an adequate width of keratinised tissue. The 3D-matrix shows excellent handling properties and can be used successfully in an open healing situation, reducing significantly patient morbidity and surgery time compared to CTG.
Case by Prof. Dr. Mariano Sanz and Dr. Ramón Lorenzo, Madrid, Spain
Presence of a band of keratinised tissue (4 mm) 6 months after treatment.
(Sanz M, et al. J Clin Periodontol. 2009 Oct;36(10):868-76 * Mucograft® (prototype) exhibited highly similar physical, mechanical and biological properties to the final product Geistlich Mucograft® differing only in the porcine collagen source used.)
Not all products presented on this website are registered and approved for sale and usage in all countries or regions by the relevant authorities. Indications of use may also vary by country and region. Please contact your country representative of Geistlich Pharma AG for product availability and information.